Sexually transmitted infection HPV raises reinjection risk in men- study

A study says that men infected with a particular type of genital human papillomavirus (HPV) may be at twenty times more risk of reinfection with the same type. The findings show that men who are infected once with HPV16, the type responsible for most HPV-related cancers, are at 20 times higher risk of reinfection after one year, and 14 times higher after two years.  HPV is the most common sexually transmitted infection and it is a major cause of genital warts and cancers of the genitals, mouth and throat.  The same effect was observed in both men who are sexually active and celibate, suggesting that they are not reacquiring the virus from another sexual partner. This increased risk suggests that infection confers no natural immunity against HPV, and emphasises the importance of vaccination for preventing the spread of HPV in young men before they become sexually active.  Vaccination could potentially prevent reinfection in older men who have already contracted the virus, the researchers said. “Vaccinating boys before HPV exposure could be a highly effective way to reduce the burden of HPV infection. Vaccinating men who have already been infected might also be effective,” said lead author Sylvia Ranjeva, doctoral student at the University of Chicago. For the study, published in the Proceedings of the National Academy of Sciences, the team analysed data of over 4,000 unvaccinated men from three cities in Florida, Mexico and Brazil to understand what allowed over 200 genetically-distinct HPV types to coexist.  The researchers found that the diversity of HPV types may stem from recurring infections of particular types within individuals.  While relatively few people are infected with any one type, the high overall HPV prevalence occurs because nearly half the adult population carries at least one type of genital HPV.